Iterum Therapeutics Reports First Quarter 2020 Financial Results
–Phase 3 topline results from sulopenem clinical trials in uUTI and cUTI expected Q2 —— Raised $51.6 million through a […]
TCR² Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
Continued progress on treatment of TC-210 patients with interim update from Phase 1 portion of Phase 1/2 clinical trial anticipated […]
TSX News -
Bombardier’s FLEXITY high-floor trams authorized for the Düsseldorf network
Modern FLEXITY trams have achieved authorization to operate in the Düsseldorf metropolitan areaThe new generation of FLEXITY trams are energy […]
TSX News -
MediPharm Labs Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with Biopharmaceutical Leader Avicanna Inc.
BARRIE, Ontario, May 14, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or […]
InfuSystem Holdings, Inc. Reports First Quarter 2020 Financial Results
ROCHESTER HILLS, Michigan, May 14, 2020 (GLOBE NEWSWIRE) — InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a […]
Kaleido Biosciences Provides Corporate Update and Reports First Quarter 2020 Financial Results
– Initiating Clinical Studies of KB109 in Outpatients with Mild-to-Moderate COVID-19; Data Anticipated in Q4 2020 –– Expanding Work in […]
Kaleido Biosciences Initiates Controlled Clinical Study of Microbiome Metabolic Therapy KB109 in Outpatients with Mild-to-Moderate COVID-19
– Top-Line Data from Study of Approximately 350 Patients Expected in Q4 2020 – – Second Clinical Study [...]
TSX News -
MediPharm Labs to File First Quarter Financial Statements and MD&A in June 2020, Provides Q1 Update
BARRIE, Ontario, May 14, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or […]
QMX Gold Grants Option to O3 Mining for the Aurbel Mill
TORONTO, May 14, 2020 (GLOBE NEWSWIRE) — QMX Gold Corporation (“QMX” or the “Company”) (TSX:V:QMX) is pleased to announce that […]
BriaCell Announces Presentation and Abstract Publication at 2020 American Society of Clinical Oncology (ASCO) Meeting
New data and pathological findings on BriaCell’s lead candidate, Bria-IMT™, to be Highlighted at ASCO 2020 in a Poster PresentationBERKELEY, […]
